CONNECT WITH US
Web3 & Blockchain

Web3 & Blockchain

INJ Price Prediction: Cup-and-Handle Eyes $14 as Deleveraging Tests the Near-Term Floor

Blockchain.News logo

Published on

Add as a preferred source on Google
INJ Price Prediction: Cup-and-Handle Eyes $14 as Deleveraging Tests the Near-Term Floor

Injective (INJ) fell 4.66% to $8.78 on October 17, with Binance futures open interest contracting 12.57% in 24 hours and taker sell volume outpacing buys. The token holds above all tracked moving a...

Market analysis includes conditional scenarios, not assured price outcomes or investment advice. Check the data, assumptions and dates cited.

INJ entered October 17 under clear pressure. The token shed 4.66% within 24 hours, printing at $8.78 across a session range of $8.46 to $9.41 on Binance spot, with volume registering approximately $28.8 million. That range alone is notable: the session high of $9.41 cleared both immediate resistance at $9.31 and moved within striking distance of strong resistance at $9.84 before sellers intervened and pushed the price back below the pivot point of $8.88.

Despite the drop, the moving average stack remains entirely supportive. INJ trades above its 7-day SMA ($8.13), 20-day SMA ($7.70), 50-day SMA ($6.83), and 200-day SMA ($5.15), along with the EMA 12 ($8.01) and EMA 26 ($7.61). A token sitting above all six tracked averages—short, medium, and long-term—carries a structurally bullish configuration. That configuration does not prevent further near-term weakness, but it does establish the trend context in which any pullback is currently occurring.

The Bollinger Band picture adds important texture. 0193 confirms that the current price sits marginally above the upper band. 70.



Source link
Related Topics:Web3 & Blockchain

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.